Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vi Polysaccharide Vaccine Against Typhoid Fever in Eastern Kolkata
NCT00125008Phase 4Completed
- Sponsor
- International Vaccine Institute
- Start
- May 2003
- Primary completion
- Jan 2008
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised trial of salmonella typhi capsular polysaccharide vaccine in typhoid fever (2 arms), sponsored by International Vaccine Institute. Primary endpoint: Total protection against S. typhi at 2 years. Started May 2003; status: completed.
02
Drugs
salmonella typhi capsular polysaccharide vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT00125008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125008.